Project 4214
Adaptation of the Minimum Anticipated Biological Effect Level (MABEL) Approach to Emerging Compounds of Interest
$145,329
Principal Investigator
Richard Pleus
Project Manager
Djanette Khiari
Contractor
Intertox Inc.
Abstract
Developed and applied an innovative scientifically-based method to develop health-protective Acceptable Daily Intakes (ADIs) for new compounds of emerging interest to the water industry that have the potential for significant toxicity to sensitive population groups, including pharmaceutical and personal care product (PPCP) ingredients, hormonally active compounds, and nanomaterials. Published in 2011.
Related Projects
Project 4992
Project 4972
Project 4874
Project 5125
Project 5171
Project 5088